Home > Publications > Medical Specialty > Internal Medicine > Gastroenterology > Inflammatory Bowel Disease > Inflammatory Bowel Disease Research Review, Issue 91
Inflammatory Bowel Disease Research Review, Issue 91

Inflammatory Bowel Disease Research Review, Issue 91

In this issue:

Adding appendicectomy to standard medical therapy for maintaining UC remission
1-year of guselkumab vs. advanced therapies for moderate-to-severe CD
Long-term outcomes after TNF inhibitor withdrawal in IBD in remission
Biologics within 12 months of CD diagnosis: greater transmural healing
Epidemiology of elderly-onset IBD
Role of prediagnosis environmental factors on IBD activity and severity
Etrasimod with concomitant opioids/antidepressants in UC
Rectal tacrolimus in UC
Efficacy of biologics and small molecules in maintenance UC therapy
Vedolizumab in patients aged ≥70 vs. <70 years with UC

You need to be logged in to access this content.

Dr-Alex-Barnes

Expert contributor

Dr Alex Barnes

Dr Barnes is an academic gastroenterologist with the inflammatory bowel disease unit at Flinders Medical Centre and works privately with IBD SA. Dr Barnes trained at Flinders Medical Centre and the Royal Adelaide Hospital, completing an IBD fellowship at Flinders Medical. He has completed a Masters of Public Health and a PhD examining the significance […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.